The Vetr community downgraded Pfizer Inc. PFE from 3.5 stars to 3 stars.
Pfizer shares have settled into a steady trading range over the past six months between $31 and $34, and the company's first-quarter earnings report in May showed a slight beat on the EPS estimate and a slight miss on the revenue estimate.
See how crowdsourced ratings can help predict the market?
Vetr members have given Pfizer a Hold rating and $34.50 price target. This price target is lower than the $37.87 price target from Wall Street analysts. The company opened Wednesday around $33.
Of all Vetr raters, about 57 percent believe traders and investors should buy Pfizer stock.
For Vetr's full analysis of Pfizer, go here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.